Re: Research Subject's negligence in clinical trials Deb Birgen 02 Aug 2005 11:15 EST
I would have several questions/issues with this. First, I'm not sure that it is legal or would be approved by your IRB. You may want to clear this with them before you spend a lot of time on it. Second, it is too vague - if a patient forgets to take pill, would that constitute negligence? Third, for a master agreement, it would be very difficult to define correctly. Since each study will have a different population with diverse abilities and problems (children, Alzheimer's patients, etc.) it would be a mine-field. Deb Birgen 206.543.4043 -----Original Message----- From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On Behalf Of Beyea, Donna L. Sent: Tuesday, 02 Aug 2005 06:11 AM To: xxxxxx@HRINET.ORG Subject: [RESADM-L] Research Subject's negligence in clinical trials We are having extreme difficulty in getting some pharmaceutical sponsors to delete reference to the study subject's negligence in the indemnification language in their clinical trial agreements. We have been rather successful in getting out language that implies the reseach subject must follow directions, however, we've run into some other road blocks. Specifically, Novartis and a couple of other sponsors include language that states that they will indemnify us provided: Such liability, claim, action and/or suit does not arise out of the negligence or willful malfeasance of any Indemnitee, or any other person on the Institution's property, exclusive of [the sponsor's] employees; We have specifically been told by Novartis that this is meant to include the research subject. Hence my question - does your institution accept this language and thereby accept responsibility for the study subjects negligence in addition to the negligence of your own employees? Have any of you been successful in negotiating a Master Clinical Trial Agreement with Novartis in which they have agreed to remove this language or stipulate that it doesn't include the research subject? Any additional arguments I can gather would be greatlly appreciated. Thanks Donna ********************************** Donna L. Beyea Senior Research Administrator University of Rochester Office of Research and Project Administration 509 Hylan Building - Box 270140 Rochester, NY 14627 Phone: 585-275-8037 Fax: 585-275-9492 email: xxxxxx@rochester.edu ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================